Skip to main content
Top
Published in: Systematic Reviews 1/2022

Open Access 01-12-2022 | Lymphoma | Research

Mapping evidence on the risk factors associated with pediatric cancers in sub-Saharan Africa: a scoping review

Authors: Sehlisiwe Ndlovu, Mbuzeleni Hlongwa, Themba Ginindza

Published in: Systematic Reviews | Issue 1/2022

Login to get access

Abstract

Background

The rarity and heterogeneity of pediatric cancers make it difficult to assess risk factors associated with the development of cancer in this group. This also determines the quantity and quality of evidence for etiological factors linked to pediatric cancers. Evidence on the risk factors associated with pediatric cancers is scarce; however, it has been accumulating slowly over the years. As the disease burden shifts from communicable to non-communicable diseases, most of these low- to middle-income countries (LMICs) find themselves overburdened with changing health care priorities and needs. In sub-Saharan Africa, it is of major importance to pay particular attention to risk factors associated with pediatric cancer.

Objective

To map evidence on risk factors associated with pediatric cancers in sub-Saharan Africa (SSA).

Methods

This review was guided by Arksey and O’Malley’s framework for conducting scoping reviews. Four electronic databases were searched in December 2018, and another manual search was conducted in February 2022 to include newly published eligible articles. The databases searched included PubMed and Health Source: Nursing/Academic Edition. We also searched articles from an academic search engine, Google scholar. This review included articles reporting the relevant outcomes of this study and articles reporting cancers in children in the 0–15 years age range. This review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping reviews (PRISMA-ScR): checklist and explanation.

Results

We retrieved 7391 articles from the initial database. The final number of studies that were included for data extraction was 15. Evidence from the retrieved studies suggests that most childhood cancers in the SSA region are infection-induced. The type of cancer mostly reported is Burkitt Lymphoma and is diagnosed mostly in the tropical region of SSA. The type of risk factors was divided into three types: infection-induced, genetic, and demographic risk factors. Overall, based on the articles retrieved, there was limited evidence on the risk factors associated with pediatric cancers in SSA.

Conclusion

The limited evidence on the risk factors coupled with the lack of evidence on the true burden of these malignancies in the SSA hampers efforts to set priorities for childhood cancer control. Formulation of effective preventative (where possible) measures and treatment regimens will need proper assessment of risk factors.
Literature
1.
go back to reference Buka I, Koranteng S, Osornio Vargas AR. Trends in childhood cancer incidence: review of environmental linkages. Pediatr Clin N Am. 2007;54(1):177–203.CrossRef Buka I, Koranteng S, Osornio Vargas AR. Trends in childhood cancer incidence: review of environmental linkages. Pediatr Clin N Am. 2007;54(1):177–203.CrossRef
2.
go back to reference Magrath I, et al. Paediatric cancer in low-income and middle-income countries. Lancet Oncol. 2013;14(3):e104–16.PubMedCrossRef Magrath I, et al. Paediatric cancer in low-income and middle-income countries. Lancet Oncol. 2013;14(3):e104–16.PubMedCrossRef
3.
go back to reference Spector LG, Pankratz N, Marcotte EL. Genetic and nongenetic risk factors for childhood cancer. Pediatr Clin N Am. 2015;62(1):11–25.CrossRef Spector LG, Pankratz N, Marcotte EL. Genetic and nongenetic risk factors for childhood cancer. Pediatr Clin N Am. 2015;62(1):11–25.CrossRef
4.
go back to reference Scheurer ME, et al. An overview of disparities in childhood cancer: report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. Pediatr Hematol Oncol. 2018;35(2):95–110.PubMedPubMedCentralCrossRef Scheurer ME, et al. An overview of disparities in childhood cancer: report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. Pediatr Hematol Oncol. 2018;35(2):95–110.PubMedPubMedCentralCrossRef
5.
go back to reference Degar B, Isakoff M. Chapter 123 - childhood cancer. In: Zaoutis LB, Chiang VW, editors. Comprehensive pediatric hospital medicine. Philadelphia: Mosby; 2007. p. 774–9.CrossRef Degar B, Isakoff M. Chapter 123 - childhood cancer. In: Zaoutis LB, Chiang VW, editors. Comprehensive pediatric hospital medicine. Philadelphia: Mosby; 2007. p. 774–9.CrossRef
6.
go back to reference Linet MS, Wacholder S, Zahm SH. Interpreting epidemiologic research: lessons from studies of childhood cancer. Pediatrics. 2003;112(Supplement 1):218–32.PubMedCrossRef Linet MS, Wacholder S, Zahm SH. Interpreting epidemiologic research: lessons from studies of childhood cancer. Pediatrics. 2003;112(Supplement 1):218–32.PubMedCrossRef
8.
go back to reference Alibek K, et al. Childhood cancers: what is a possible role of infectious agents? Infect Agents Cancer. 2013;8(1):48.CrossRef Alibek K, et al. Childhood cancers: what is a possible role of infectious agents? Infect Agents Cancer. 2013;8(1):48.CrossRef
9.
go back to reference Renner L, et al. Evidence from Ghana indicates that childhood cancer treatment in sub-Saharan Africa is very cost effective: a report from the childhood cancer 2030 network. J Glob Oncol. 2018;4:1–9.PubMed Renner L, et al. Evidence from Ghana indicates that childhood cancer treatment in sub-Saharan Africa is very cost effective: a report from the childhood cancer 2030 network. J Glob Oncol. 2018;4:1–9.PubMed
11.
go back to reference Ndlovu SR, Kuupiel D, Ginindza TG. Mapping evidence on the distribution of paediatric cancers in sub-Saharan Africa: a scoping review protocol. Syst Rev. 2019;8(1):262.PubMedPubMedCentralCrossRef Ndlovu SR, Kuupiel D, Ginindza TG. Mapping evidence on the distribution of paediatric cancers in sub-Saharan Africa: a scoping review protocol. Syst Rev. 2019;8(1):262.PubMedPubMedCentralCrossRef
13.
go back to reference Akang E. Tumors of childhood in Ibadan, Nigeria (1973-1990). Pediatr Pathol Lab Med. 1996;16(5):791–800.PubMedCrossRef Akang E. Tumors of childhood in Ibadan, Nigeria (1973-1990). Pediatr Pathol Lab Med. 1996;16(5):791–800.PubMedCrossRef
14.
go back to reference Amir H, et al. Kaposi’s sarcoma before and during a human immunodeficiency virus epidemic in Tanzanian children. Pediatr Infect Dis J. 2001;20(5):518–21.PubMedCrossRef Amir H, et al. Kaposi’s sarcoma before and during a human immunodeficiency virus epidemic in Tanzanian children. Pediatr Infect Dis J. 2001;20(5):518–21.PubMedCrossRef
15.
go back to reference Athale UH, et al. Influence of HIV epidemic on the incidence of Kaposi's sarcoma in Zambian children. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8(1):96–100.PubMedCrossRef Athale UH, et al. Influence of HIV epidemic on the incidence of Kaposi's sarcoma in Zambian children. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8(1):96–100.PubMedCrossRef
16.
go back to reference Dauda MA, et al. Sarcomas in Nigerian children in Jos North Central Nigeria. Afr J Med Med Sci. 2014;43(Suppl 1):37–44.PubMedPubMedCentral Dauda MA, et al. Sarcomas in Nigerian children in Jos North Central Nigeria. Afr J Med Med Sci. 2014;43(Suppl 1):37–44.PubMedPubMedCentral
17.
go back to reference Davidson A, et al. Malignancies in South African children with HIV. J Pediatr Hematol Oncol. 2014;36(2):111–7.PubMedCrossRef Davidson A, et al. Malignancies in South African children with HIV. J Pediatr Hematol Oncol. 2014;36(2):111–7.PubMedCrossRef
18.
go back to reference Ekenze SO, et al. The burden of pediatric malignant solid tumors in a developing country. J Trop Pediatr. 2009;56(2):111–4.PubMedCrossRef Ekenze SO, et al. The burden of pediatric malignant solid tumors in a developing country. J Trop Pediatr. 2009;56(2):111–4.PubMedCrossRef
19.
go back to reference Fraumeni JF Jr, Miller RW, Hill JA. Primary carcinoma of the liver in childhood: an epidemiologic study. J Natl Cancer Inst. 1968;40(5):1087–99.PubMed Fraumeni JF Jr, Miller RW, Hill JA. Primary carcinoma of the liver in childhood: an epidemiologic study. J Natl Cancer Inst. 1968;40(5):1087–99.PubMed
21.
go back to reference Gupta S, et al. Pediatric oncology as the next global child health priority: the need for national childhood cancer strategies in low-and middle-income countries. PLoS Med. 2014;11(6):e1001656.PubMedPubMedCentralCrossRef Gupta S, et al. Pediatric oncology as the next global child health priority: the need for national childhood cancer strategies in low-and middle-income countries. PLoS Med. 2014;11(6):e1001656.PubMedPubMedCentralCrossRef
22.
23.
go back to reference Kerr DA, Kaschula ROC. Pediatric pathology services in Africa. Arch Pathol Lab Med. 2013;137(6):767–74.PubMedCrossRef Kerr DA, Kaschula ROC. Pediatric pathology services in Africa. Arch Pathol Lab Med. 2013;137(6):767–74.PubMedCrossRef
24.
go back to reference Kramárová E, Stiller CA. The international classification of childhood cancer. Int J Cancer. 1996;68(6):759–65.PubMedCrossRef Kramárová E, Stiller CA. The international classification of childhood cancer. Int J Cancer. 1996;68(6):759–65.PubMedCrossRef
25.
26.
go back to reference McBride ML. Childhood cancer and environmental contaminants. Can J Public Health. 1998;89(1):53–62. McBride ML. Childhood cancer and environmental contaminants. Can J Public Health. 1998;89(1):53–62.
27.
go back to reference Moore SW, et al. Malignant liver tumors in South African children: a national audit. World J Surg. 2008;32(7):1389–95.PubMedCrossRef Moore SW, et al. Malignant liver tumors in South African children: a national audit. World J Surg. 2008;32(7):1389–95.PubMedCrossRef
28.
go back to reference Mulama DH, et al. Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case–control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer. Int J Cancer. 2014;134(3):645–53.PubMedCrossRef Mulama DH, et al. Sickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case–control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancer. Int J Cancer. 2014;134(3):645–53.PubMedCrossRef
30.
go back to reference Ochicha O, Gwarzo AK, Gwarzo D. Pediatric malignancies in Kano, northern Nigeria. World J Pediatr. 2012;8(3):235–9.PubMedCrossRef Ochicha O, Gwarzo AK, Gwarzo D. Pediatric malignancies in Kano, northern Nigeria. World J Pediatr. 2012;8(3):235–9.PubMedCrossRef
31.
go back to reference Ojesina AI, Akang EEU, Ojemakinde KO. Decline in the frequency of Burkitt’s lymphoma relative to other childhood malignancies in Ibadan, Nigeria. Ann Trop Paediatr. 2002;22(2):159–63.PubMedCrossRef Ojesina AI, Akang EEU, Ojemakinde KO. Decline in the frequency of Burkitt’s lymphoma relative to other childhood malignancies in Ibadan, Nigeria. Ann Trop Paediatr. 2002;22(2):159–63.PubMedCrossRef
32.
go back to reference Orem J, Otieno MW, Remick SC. AIDS-associated cancer in developing nations. Curr Opin Oncol. 2004;16(5):468–76.PubMedCrossRef Orem J, Otieno MW, Remick SC. AIDS-associated cancer in developing nations. Curr Opin Oncol. 2004;16(5):468–76.PubMedCrossRef
33.
go back to reference Parkin DM. Part I: Cancer in Indigenous Africans--burden, distribution, and trends. Lancet Oncol. 2008;9(7):683–92.PubMedCrossRef Parkin DM. Part I: Cancer in Indigenous Africans--burden, distribution, and trends. Lancet Oncol. 2008;9(7):683–92.PubMedCrossRef
34.
go back to reference Pollock BH, et al. Risk factors for pediatric human immunodeficiency virus–related malignancy. JAMA. 2003;289(18):2393–9.PubMedCrossRef Pollock BH, et al. Risk factors for pediatric human immunodeficiency virus–related malignancy. JAMA. 2003;289(18):2393–9.PubMedCrossRef
35.
go back to reference Pritchard-Jones K. Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries. Lancet Oncol. 2013;14(3):95.CrossRef Pritchard-Jones K. Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries. Lancet Oncol. 2013;14(3):95.CrossRef
36.
go back to reference Rainey JJ, et al. Spatial distribution of Burkitt’s lymphoma in Kenya and association with malaria risk. Tropical Med Int Health. 2007;12(8):936–43.CrossRef Rainey JJ, et al. Spatial distribution of Burkitt’s lymphoma in Kenya and association with malaria risk. Tropical Med Int Health. 2007;12(8):936–43.CrossRef
37.
go back to reference Smith MA, et al. Evidence that childhood acute lymphoblastic leukemia is associated with an infectious agent linked to hygiene conditions. Cancer Causes Control. 1998;9(3):285–98.PubMedCrossRef Smith MA, et al. Evidence that childhood acute lymphoblastic leukemia is associated with an infectious agent linked to hygiene conditions. Cancer Causes Control. 1998;9(3):285–98.PubMedCrossRef
38.
go back to reference Stefan D, et al. Childhood cancer incidence in South Africa, 1987–2007. S Afr Med J. 2015;105(11):939–47.PubMedCrossRef Stefan D, et al. Childhood cancer incidence in South Africa, 1987–2007. S Afr Med J. 2015;105(11):939–47.PubMedCrossRef
39.
go back to reference Stefan DC. Patterns of distribution of childhood cancer in Africa. J Trop Pediatr. 2015;61(3):165–73.PubMedCrossRef Stefan DC. Patterns of distribution of childhood cancer in Africa. J Trop Pediatr. 2015;61(3):165–73.PubMedCrossRef
40.
go back to reference Stefan DC. Childhood cancer in Africa: an overview of resources. J Pediatr Hematol Oncol. 2015;37(2):104–8.PubMedCrossRef Stefan DC. Childhood cancer in Africa: an overview of resources. J Pediatr Hematol Oncol. 2015;37(2):104–8.PubMedCrossRef
42.
go back to reference Stefan DC, Lutchman R. Burkitt lymphoma: epidemiological features and survival in a South African centre. Infect Agents Cancer. 2014;9(1):19.CrossRef Stefan DC, Lutchman R. Burkitt lymphoma: epidemiological features and survival in a South African centre. Infect Agents Cancer. 2014;9(1):19.CrossRef
44.
go back to reference Stones DK, et al. Childhood cancer survival rates in two South African units. S Afr Med J. 2014;104(7):501–4.PubMedCrossRef Stones DK, et al. Childhood cancer survival rates in two South African units. S Afr Med J. 2014;104(7):501–4.PubMedCrossRef
45.
go back to reference Usman B, Mohammed A. Carcinoma in children at Ahmadu Bello University Teaching Hospital Zaria. Ann Niger Med. 2015;9(2):61–5.CrossRef Usman B, Mohammed A. Carcinoma in children at Ahmadu Bello University Teaching Hospital Zaria. Ann Niger Med. 2015;9(2):61–5.CrossRef
46.
go back to reference Ward E, et al. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103.PubMedCrossRef Ward E, et al. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103.PubMedCrossRef
47.
48.
go back to reference Wessels G, Hesseling PB. Incidence and frequency rates of childhood cancer in Namibia. S Afr Med J. 1997;87(7):885–9.PubMed Wessels G, Hesseling PB. Incidence and frequency rates of childhood cancer in Namibia. S Afr Med J. 1997;87(7):885–9.PubMed
49.
51.
go back to reference Kruger M, et al. Retinoblastoma outcome at a single institution in South Africa. S Afr Med J. 2014;104(12):859–63.PubMedCrossRef Kruger M, et al. Retinoblastoma outcome at a single institution in South Africa. S Afr Med J. 2014;104(12):859–63.PubMedCrossRef
52.
go back to reference Athale UH, et al. HIV epidemic on the Influence of incidence of Kaposi’s sarcoma in Zambian children. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8(1):96–100.PubMedCrossRef Athale UH, et al. HIV epidemic on the Influence of incidence of Kaposi’s sarcoma in Zambian children. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8(1):96–100.PubMedCrossRef
53.
go back to reference Ziegler JL, et al. Risk factors for Kaposi’s sarcoma in HIV-positive subjects in Uganda. Aids. 1997;11(13):1619–26.PubMedCrossRef Ziegler JL, et al. Risk factors for Kaposi’s sarcoma in HIV-positive subjects in Uganda. Aids. 1997;11(13):1619–26.PubMedCrossRef
56.
go back to reference Makata AM, et al. The pattern of pediatric solid malignant tumors in western Kenya, east Africa, 1979–1994: an analysis based on histopathologic study. Am J Trop Med Hyg. 1996;54(4):343–7.PubMedCrossRef Makata AM, et al. The pattern of pediatric solid malignant tumors in western Kenya, east Africa, 1979–1994: an analysis based on histopathologic study. Am J Trop Med Hyg. 1996;54(4):343–7.PubMedCrossRef
57.
go back to reference Mutalima N, et al. Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and Malaria: results from a case-control study. PLoS One. 2008;3(6):e2505.PubMedPubMedCentralCrossRef Mutalima N, et al. Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and Malaria: results from a case-control study. PLoS One. 2008;3(6):e2505.PubMedPubMedCentralCrossRef
58.
go back to reference Mutalima N, et al. Impact of infection with human immunodeficiency virus-1 (HIV) on the risk of cancer among children in Malawi - preliminary findings. Infect Agents Cancer. 2010;5(1):5.CrossRef Mutalima N, et al. Impact of infection with human immunodeficiency virus-1 (HIV) on the risk of cancer among children in Malawi - preliminary findings. Infect Agents Cancer. 2010;5(1):5.CrossRef
59.
go back to reference Newton R, et al. A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer. 2001;92(5):622–7.PubMedCrossRef Newton R, et al. A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer. 2001;92(5):622–7.PubMedCrossRef
61.
go back to reference Sinfield RL, et al. Spectrum and presentation of pediatric malignancies in the HIV era: experience from Blantyre, Malawi, 1998–2003. Pediatr Blood Cancer. 2007;48(5):515–20.PubMedCrossRef Sinfield RL, et al. Spectrum and presentation of pediatric malignancies in the HIV era: experience from Blantyre, Malawi, 1998–2003. Pediatr Blood Cancer. 2007;48(5):515–20.PubMedCrossRef
62.
go back to reference Ferndale L, et al. Gender differences in oesophageal squamous cell carcinoma in a South African Tertiary Hospital. Int J Environ Res Public Health. 2020;17(19):7086.PubMedCentralCrossRef Ferndale L, et al. Gender differences in oesophageal squamous cell carcinoma in a South African Tertiary Hospital. Int J Environ Res Public Health. 2020;17(19):7086.PubMedCentralCrossRef
63.
go back to reference Harlemon M, et al. A custom genotyping array reveals population-level heterogeneity for the genetic risks of prostate cancer and other cancers in Africa. Cancer Res. 2020;80(13):2956–66.PubMedPubMedCentralCrossRef Harlemon M, et al. A custom genotyping array reveals population-level heterogeneity for the genetic risks of prostate cancer and other cancers in Africa. Cancer Res. 2020;80(13):2956–66.PubMedPubMedCentralCrossRef
64.
65.
go back to reference Munishi OM, et al. Awareness of cancer risk factors and its signs and symptoms in Northern Tanzania: a cross-sectional survey in the general population and in people living with HIV. J Cancer Educ. 2020;35(4):696–704.PubMedCrossRef Munishi OM, et al. Awareness of cancer risk factors and its signs and symptoms in Northern Tanzania: a cross-sectional survey in the general population and in people living with HIV. J Cancer Educ. 2020;35(4):696–704.PubMedCrossRef
66.
go back to reference Okeke E, et al. Epidemiology of liver cancer in Africa: current and future trends. Semin Liver Dis. 2020;40(2):111–23.PubMedCrossRef Okeke E, et al. Epidemiology of liver cancer in Africa: current and future trends. Semin Liver Dis. 2020;40(2):111–23.PubMedCrossRef
67.
go back to reference Parkin DM, et al. Cancer in Africa 2018: the role of infections. Int J Cancer. 2020;146(8):2089–103.PubMedCrossRef Parkin DM, et al. Cancer in Africa 2018: the role of infections. Int J Cancer. 2020;146(8):2089–103.PubMedCrossRef
68.
go back to reference Sadykova LR, et al. Epidemiology and risk factors of osteosarcoma. Cancer Investig. 2020;38(5):259–69.CrossRef Sadykova LR, et al. Epidemiology and risk factors of osteosarcoma. Cancer Investig. 2020;38(5):259–69.CrossRef
69.
go back to reference Vo Quang E, Shimakawa Y, Nahon P. Epidemiological projections of viral-induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination. Liver Int. 2021;41(5):915–27.PubMedCrossRef Vo Quang E, Shimakawa Y, Nahon P. Epidemiological projections of viral-induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination. Liver Int. 2021;41(5):915–27.PubMedCrossRef
70.
go back to reference Peprah S, et al. Risk factors for Burkitt lymphoma in East African children and minors: a case-control study in malaria-endemic regions in Uganda, Tanzania and Kenya. Int J Cancer. 2020;146(4):953–69.PubMedCrossRef Peprah S, et al. Risk factors for Burkitt lymphoma in East African children and minors: a case-control study in malaria-endemic regions in Uganda, Tanzania and Kenya. Int J Cancer. 2020;146(4):953–69.PubMedCrossRef
71.
go back to reference Redmond LS, et al. Endemic Burkitt lymphoma: a complication of asymptomatic malaria in sub-Saharan Africa based on published literature and primary data from Uganda, Tanzania, and Kenya. Malar J. 2020;19(1):239.PubMedPubMedCentralCrossRef Redmond LS, et al. Endemic Burkitt lymphoma: a complication of asymptomatic malaria in sub-Saharan Africa based on published literature and primary data from Uganda, Tanzania, and Kenya. Malar J. 2020;19(1):239.PubMedPubMedCentralCrossRef
72.
go back to reference Kirimunda S, et al. Variation in the Human Leukocyte Antigen system and risk for endemic Burkitt lymphoma in northern Uganda. Br J Haematol. 2020;189(3):489–99.PubMedPubMedCentralCrossRef Kirimunda S, et al. Variation in the Human Leukocyte Antigen system and risk for endemic Burkitt lymphoma in northern Uganda. Br J Haematol. 2020;189(3):489–99.PubMedPubMedCentralCrossRef
73.
74.
go back to reference Apple A, Lovvorn HN. Wilms tumor in sub-Saharan Africa: molecular and social determinants of a global pediatric health disparity. Front Oncol. 2020;10:606380.PubMedPubMedCentralCrossRef Apple A, Lovvorn HN. Wilms tumor in sub-Saharan Africa: molecular and social determinants of a global pediatric health disparity. Front Oncol. 2020;10:606380.PubMedPubMedCentralCrossRef
75.
go back to reference Parkin DMA, et al. Non-Hodgkin lymphoma in Uganda: a case-control study. AIDS. 2000;14(18):2929–36.PubMedCrossRef Parkin DMA, et al. Non-Hodgkin lymphoma in Uganda: a case-control study. AIDS. 2000;14(18):2929–36.PubMedCrossRef
76.
go back to reference Ziegler JL, Katongole-Mbidde E. Kaposi’s sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer. 1996;65(2):200–3.PubMedCrossRef Ziegler JL, Katongole-Mbidde E. Kaposi’s sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer. 1996;65(2):200–3.PubMedCrossRef
77.
go back to reference Johnson KJ, et al. Parental age and risk of childhood cancer: a pooled analysis. Epidemiology (Cambridge, Mass). 2009;20(4):475.CrossRef Johnson KJ, et al. Parental age and risk of childhood cancer: a pooled analysis. Epidemiology (Cambridge, Mass). 2009;20(4):475.CrossRef
78.
go back to reference Maule MM, et al. Effects of maternal age and cohort of birth on incidence time trends of childhood acute lymphoblastic leukemia. Cancer Epidemiol Prev Biomarkers. 2007;16(2):347–51.CrossRef Maule MM, et al. Effects of maternal age and cohort of birth on incidence time trends of childhood acute lymphoblastic leukemia. Cancer Epidemiol Prev Biomarkers. 2007;16(2):347–51.CrossRef
79.
go back to reference Maule MM, et al. How the effect of maternal age on the risk of childhood leukemia changed over time in Sweden, 1960–2004. Environ Health Perspect. 2009;117(2):299–302.PubMedCrossRef Maule MM, et al. How the effect of maternal age on the risk of childhood leukemia changed over time in Sweden, 1960–2004. Environ Health Perspect. 2009;117(2):299–302.PubMedCrossRef
80.
go back to reference Johnson KJ, et al. Perinatal characteristics and risk of neuroblastoma. Int J Cancer. 2008;123(5):1166–72.PubMedCrossRef Johnson KJ, et al. Perinatal characteristics and risk of neuroblastoma. Int J Cancer. 2008;123(5):1166–72.PubMedCrossRef
81.
go back to reference Schüz J, et al. Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol. 1999;28(4):631–9.PubMedCrossRef Schüz J, et al. Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol. 1999;28(4):631–9.PubMedCrossRef
82.
go back to reference Steliarova-Foucher E, et al. International classification of childhood cancer. Cancer. 2005;103(7):1457–67.PubMedCrossRef Steliarova-Foucher E, et al. International classification of childhood cancer. Cancer. 2005;103(7):1457–67.PubMedCrossRef
83.
go back to reference Ries LAG, et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. 1999. Ries LAG, et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. 1999.
84.
go back to reference Di Bisceglie AM, et al. Hepatitis C–related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol. 2003;98(9):2060–3.PubMed Di Bisceglie AM, et al. Hepatitis C–related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol. 2003;98(9):2060–3.PubMed
85.
go back to reference Jemal A, et al. Cancer burden in Africa and opportunities for prevention. Cancer. 2012;118(18):4372–84.PubMedCrossRef Jemal A, et al. Cancer burden in Africa and opportunities for prevention. Cancer. 2012;118(18):4372–84.PubMedCrossRef
86.
go back to reference Bisceglie A, Rustgi V, Hoofnagle J, Dusheiko G, Lotze M. Hepatocellular carcinoma. Ann Intern Med. 1988;108(3):390–401.PubMedCrossRef Bisceglie A, Rustgi V, Hoofnagle J, Dusheiko G, Lotze M. Hepatocellular carcinoma. Ann Intern Med. 1988;108(3):390–401.PubMedCrossRef
87.
go back to reference Sitas F, et al. Part II: cancer in indigenous Africans--causes and control. Lancet Oncol. 2008;9(8):786–95.PubMedCrossRef Sitas F, et al. Part II: cancer in indigenous Africans--causes and control. Lancet Oncol. 2008;9(8):786–95.PubMedCrossRef
88.
go back to reference Sitas F, et al. The spectrum of HIV-1 related cancers in South Africa. Int J Cancer. 2000;88(3):489–92.PubMedCrossRef Sitas F, et al. The spectrum of HIV-1 related cancers in South Africa. Int J Cancer. 2000;88(3):489–92.PubMedCrossRef
89.
go back to reference Rainey JJ, et al. Spatial clustering of endemic Burkitt’s lymphoma in high-risk regions of Kenya. Int J Cancer. 2007;120(1):121–7.PubMedCrossRef Rainey JJ, et al. Spatial clustering of endemic Burkitt’s lymphoma in high-risk regions of Kenya. Int J Cancer. 2007;120(1):121–7.PubMedCrossRef
90.
go back to reference Geser A, Brubaker G, Draper CC. Effect of a malaria suppression program on the incidence of African Burkitt’s lymphoma. Am J Epidemiol. 1989;129(4):740–52.PubMedCrossRef Geser A, Brubaker G, Draper CC. Effect of a malaria suppression program on the incidence of African Burkitt’s lymphoma. Am J Epidemiol. 1989;129(4):740–52.PubMedCrossRef
Metadata
Title
Mapping evidence on the risk factors associated with pediatric cancers in sub-Saharan Africa: a scoping review
Authors
Sehlisiwe Ndlovu
Mbuzeleni Hlongwa
Themba Ginindza
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2022
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-022-01931-6

Other articles of this Issue 1/2022

Systematic Reviews 1/2022 Go to the issue